Edition:
United Kingdom

Marksans Pharma Ltd (MARK.NS)

MARK.NS on National Stock Exchange of India

28.60INR
23 May 2018
Change (% chg)

Rs2.70 (+10.42%)
Prev Close
Rs25.90
Open
Rs25.75
Day's High
Rs30.10
Day's Low
Rs25.55
Volume
5,540,454
Avg. Vol
2,476,312
52-wk High
Rs52.30
52-wk Low
Rs25.30

Chart for

About

Marksans Pharma Limited is a pharmaceutical holding company. The Company is engaged in the research, manufacturing and marketing of generic pharmaceutical formulations. The Company's product portfolio addresses various therapeutic segments, including Pain management, Cough and cold, Anti-diabetic, Cardiovascular system, Central... (more)

Overall

Beta: 1.92
Market Cap(Mil.): Rs19,606.13
Shares Outstanding(Mil.): 409.31
Dividend: 0.05
Yield (%): 0.10

Financials

  MARK.NS Industry Sector
P/E (TTM): 88.58 30.95 32.75
EPS (TTM): 0.54 -- --
ROI: -- 14.84 14.38
ROE: -- 16.34 16.07

BRIEF-India's Marksans Pharma Dec-Qtr Consol Profit Rises

* DEC QUARTER CONSOL PROFIT 174.6 MILLION RUPEES VERSUS PROFIT 115.2 MILLION RUPEES YEAR AGO

12 Feb 2018

Earnings vs. Estimates